Sonoma Private Wealth LLC Gilead Sciences, Inc. Transaction History

Sonoma Private Wealth LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $428,048 - $521,994	5,980 New	5,980 $438 Million
Q3 2023 Oct 30, 2023	BUY	$73.94 - $80.67 $8,133 - $8,873	110 Added 1.18%	9,429 $707 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $34,508 - $39,361	454 Added 5.12%	9,319 $718 Million
Q1 2023 May 10, 2023	BUY	$77.31 - $88.08 $460,767 - $524,956	5,960 Added 205.16%	8,865 $736 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $181,039 - $259,910	2,905 New	2,905 $249 Million

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sonoma Private Wealth LLC, based on Form 13F filings with the SEC.

Stay updated on Sonoma Private Wealth LLC with notifications on news.